AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Patient in hospital bed

Nurse practitioners’ care linked to 11% longer stays in the ED

| 4 Min Read
Two healthcare workers in conversation

Mid-career physicians report higher burnout rates

| 6 Min Read
Patient in a wheelchair

Shape your state’s hardship exemptions to Medicaid work requirements

| 7 Min Read
Doctor with reassuring hand on smiling patient

What doctors want patients to know about lupus

| 13 Min Read